BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34502522)

  • 1. In Silico Methods for the Identification of Diagnostic and Favorable Prognostic Markers in Acute Myeloid Leukemia.
    Yılmaz H; Toy HI; Marquardt S; Karakülah G; Küçük C; Kontou PI; Logotheti S; Pavlopoulou A
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.
    Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS
    Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated approach of gene expression and DNA-methylation profiles of WNT signaling genes uncovers novel prognostic markers in acute myeloid leukemia.
    Taskesen E; Staal FJ; Reinders MJ
    BMC Bioinformatics; 2015; 16 Suppl 4(Suppl 4):S4. PubMed ID: 25734857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients.
    Lauber C; Correia N; Trumpp A; Rieger MA; Dolnik A; Bullinger L; Roeder I; Seifert M
    Sci Rep; 2020 Jul; 10(1):12761. PubMed ID: 32728112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.
    Jamalpour M; Li X; Cavelier L; Gustafsson K; Mostoslavsky G; Höglund M; Welsh M
    Tumour Biol; 2017 Oct; 39(10):1010428317720643. PubMed ID: 28982308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemia.
    Yang XH; Li M; Wang B; Zhu W; Desgardin A; Onel K; de Jong J; Chen J; Chen L; Cunningham JM
    BMC Bioinformatics; 2015 Mar; 16():97. PubMed ID: 25887548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
    Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y
    Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia.
    Pan JQ; Zhang YQ; Wang JH; Xu P; Wang W
    Int J Mol Med; 2017 Mar; 39(3):663-671. PubMed ID: 28204819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
    Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
    Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrative meta-analysis of differential gene expression in acute myeloid leukemia.
    Miller BG; Stamatoyannopoulos JA
    PLoS One; 2010 Mar; 5(3):e9466. PubMed ID: 20209125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
    Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia.
    Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Zimmermann M; Peeters JK; Valk PJ; Balgobind BV; Sonneveld E; Kaspers GJ; de Bont ES; Trka J; Baruchel A; Creutzig U; Pieters R; Reinhardt D; Zwaan CM
    Haematologica; 2011 Mar; 96(3):384-92. PubMed ID: 21134981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.
    Becker H; Marcucci G; Maharry K; Radmacher MD; Mrózek K; Margeson D; Whitman SP; Wu YZ; Schwind S; Paschka P; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Baer MR; Caligiuri MA; Larson RA; Bloomfield CD
    J Clin Oncol; 2010 Feb; 28(4):596-604. PubMed ID: 20026798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD37 high expression as a potential biomarker and association with poor outcome in acute myeloid leukemia.
    Zhang Q; Han Q; Zi J; Song C; Ge Z
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32400873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct prognostic values of Annexin family members expression in acute myeloid leukemia.
    Niu Y; Yang X; Chen Y; Jin X; Xie Y; Tang Y; Li L; Liu S; Guo Y; Li X; Duan L; Wang H
    Clin Transl Oncol; 2019 Sep; 21(9):1186-1196. PubMed ID: 30694461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-study reanalysis of 2,213 acute myeloid leukemia patients reveals age- and sex-dependent gene expression signatures.
    Roushangar R; Mias GI
    Sci Rep; 2019 Aug; 9(1):12413. PubMed ID: 31455838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia.
    Li J; Ge Z
    BMC Cancer; 2021 Apr; 21(1):475. PubMed ID: 33926391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia.
    Luo H; Qin Y; Reu F; Ye S; Dai Y; Huang J; Wang F; Zhang D; Pan L; Zhu H; Wu Y; Niu T; Xiao Z; Zheng Y; Liu T
    J Hematol Oncol; 2016 Nov; 9(1):125. PubMed ID: 27855695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
    Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
    J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AML.
    Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
    J Transl Med; 2021 May; 19(1):228. PubMed ID: 34051812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.